Nocardia farcinica brain abscess in a patient without immunocompromise

Br J Neurosurg. 2007 Jun;21(3):301-3. doi: 10.1080/02688690701365770.

Abstract

Brain abscess has an incidence of 1 per 100,000 in developed countries and a mortality rate of 10%. Cerebral infections with Nocardia farcinica have a mortality of up to 90%. Nocardial species are important pathogens in immunocompromised hosts, but infections in immunocompetent patients are extremely rare. We report a case of primary brain abscess with N. farcinica in a patient without immunosuppression, which was treated with surgery and a one-year course of oral moxifloxacin.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Aza Compounds / therapeutic use
  • Brain Abscess / diagnostic imaging
  • Brain Abscess / drug therapy
  • Brain Abscess / microbiology*
  • Fluoroquinolones
  • Humans
  • Immunocompetence
  • Male
  • Middle Aged
  • Moxifloxacin
  • Nocardia / isolation & purification
  • Nocardia Infections / complications*
  • Nocardia Infections / drug therapy
  • Quinolines / therapeutic use
  • Radiography

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin